Skip to main content

Board of Directors


Josef Penninger

ScienTific Director

Josef Penninger, MD was formerly a lead researcher at the Amgen Research Institute in Toronto. In 2002 he accepted the appointment as founding director of the newly established Institute of Molecular Biotechnology (IMBA) of the Austrian Academy of Sciences in Vienna, Austria. Major achievements include pioneering insights into the molecular basis of osteoporosis and breast cancer, as well as the study of metastatic spread. His group has also developed the first haploid embryonic stem cells for functional genetics.  Josef Penninger’s major awards include the Descartes Prize, the Wittgenstein Prize of the Austrian Federal Government, the Ernst Jung Prize for medical excellence, an AAAS Award the Innovator Award from Era of Hope/DOD and a second ERC Advanced grant.


Jürgen Knoblich

Deputy Scientific Director

Jürgen Knoblich obtained his PhD at the Max Planck Institute in Tübingen. He worked for three years at the Univ. of California in San Francisco before he became a group leader at the IMP in 1997. In 2004, he joined IMBA as a senior scientist and became deputy director in 2005. Jürgen Knoblich has received several awards such as the Wittgenstein prize, the Schroedinger award, the FEBS anniversary award as well as two Advanced Research Grants from the ERC. He is a member of the European Molecular Biology Organisation (EMBO), the Academia Europaea and the Austrian Academy of Sciences. He acts on the EMBO Council and the editorial boards of Current Biology, the European Journal of Cell Biology, Current Opinion in Cell Biology and the Journal of Cell Biology.


Michael Krebs

Administrative Director

Michael Krebs joined the institute in January 2004 and has a degree in Business Adminis­tration as well as an Executive MBA in “Mergers & Acquisitions”. Prior to IMBA, Michael worked for more than 5 years for early stage Biotech companies as a co-founder, CFO, and external consultant. In addition, he brings in 8 years of experience as a Senior Consultant in corporate finance, auditing, and management consulting with Arthur Andersen and as a Project Manager with the global strategy consulting firms L.E.K. Consulting (Spin-off from Bain & Co.) and Mitchell Madison Group (Spin-off from McKinsey / A.T. Kearney). At IMBA, Michael bears responsibility for all financial, administrative and business-related matters.

Representatives of the Austrian Academy of Sciences

Anton Zeilinger

President of the Austrian Academy of Sciences

Michael Alram

Vice president  of the Austrian Academy of Sciences


Steering Committee

IMBA and IMP operate as a joint initiative of the Austrian Academy of Science and Boehringer Ingelheim. For managing general and strategic issues of the cooperation a steering committee was established consisting of high-level representatives from every organisation involved.

IMBA - Institute of Molecular Biotechnology, Vienna, Austria

  • Josef Penninger
  • Michael Krebs
  • Jürgen Knoblich

Austrian Academy of Sciences (ÖAW), Vienna, Austria

  • Anton Zeilinger

Boehringer Ingelheim

  • Michel Pairet, Boehringer Ingelheim GmbH, Ingelheim, Germany
  • Phillipp von Lattorff , Boehringer Ingelheim Regional Centers Vienna, Austria

IMP - Research Institute of Molecular Pathology, Vienna, Austria

  • Harald Isemann
  • Jan Michael Peters
  • Meinrad Busslinger